Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Weydt

Showing results (71-80 of 108) with videos related to

Pageof 11
Sort By:
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 1, 2018
Provision of assistive technology devices among people with ALS in Germany: a platform-case management approachAndreas Funke, Susanne Spittel, Torsten Grehl, et al.
Neurobiology of Disease|June 8, 2013
Dynein mutations associated with hereditary motor neuropathies impair mitochondrial morphology and function with ageJudith Eschbach, Jérôme Sinniger, Jamal Bouitbir, et al.
Annals of Neurology|November 4, 2014
Mutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerizationJudith Eschbach, Björn von Einem, Kathrin Müller, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 17, 2026
ALS motor phenotypes: a revised 'OPM' classificationThomas Meyer, Nicola Ticozzi, Markus Weber, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 20, 2026
Minimum important slowing of disease progression as determined by the ALS functional rating scale - a survey of patient expectations toward disease-modifying drugs in ALSThomas Meyer, André Maier, Torsten Grehl, et al.
EMBO Molecular Medicine|April 15, 2017
Poly-GP in cerebrospinal fluid links <i>C9orf72</i>-associated dipeptide repeat expression to the asymptomatic phase of ALS/FTDCarina Lehmer, Patrick Oeckl, Jochen H Weishaupt, et al.
Ebiomedicine|March 14, 2023
Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriersJohannes Dorst, Patrick Weydt, David Brenner, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 23, 2015
Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patientsPetra Steinacker, Emily Feneberg, Jochen Weishaupt, et al.
Scientific Reports|June 10, 2022
Use and subjective experience of the impact of motor-assisted movement exercisers in people with amyotrophic lateral sclerosis: a multicenter observational studyAndré Maier, Marcel Gaudlitz, Torsten Grehl, et al.
Science Translational Medicine|January 29, 2025
Early-onset sleep alterations found in patients with amyotrophic lateral sclerosis are ameliorated by orexin antagonist in mouse modelsSimon J Guillot, Christina Lang, Marie Simonot, et al.
Pageof 11

Showing results (71-80 of 108) with videos related to

Sort By:
Pageof 11
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|February 1, 2018
Provision of assistive technology devices among people with ALS in Germany: a platform-case management approachAndreas Funke, Susanne Spittel, Torsten Grehl, et al.
Neurobiology of Disease|June 8, 2013
Dynein mutations associated with hereditary motor neuropathies impair mitochondrial morphology and function with ageJudith Eschbach, Jérôme Sinniger, Jamal Bouitbir, et al.
Annals of Neurology|November 4, 2014
Mutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerizationJudith Eschbach, Björn von Einem, Kathrin Müller, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 17, 2026
ALS motor phenotypes: a revised 'OPM' classificationThomas Meyer, Nicola Ticozzi, Markus Weber, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|January 20, 2026
Minimum important slowing of disease progression as determined by the ALS functional rating scale - a survey of patient expectations toward disease-modifying drugs in ALSThomas Meyer, André Maier, Torsten Grehl, et al.
EMBO Molecular Medicine|April 15, 2017
Poly-GP in cerebrospinal fluid links <i>C9orf72</i>-associated dipeptide repeat expression to the asymptomatic phase of ALS/FTDCarina Lehmer, Patrick Oeckl, Jochen H Weishaupt, et al.
Ebiomedicine|March 14, 2023
Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriersJohannes Dorst, Patrick Weydt, David Brenner, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 23, 2015
Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patientsPetra Steinacker, Emily Feneberg, Jochen Weishaupt, et al.
Scientific Reports|June 10, 2022
Use and subjective experience of the impact of motor-assisted movement exercisers in people with amyotrophic lateral sclerosis: a multicenter observational studyAndré Maier, Marcel Gaudlitz, Torsten Grehl, et al.
Science Translational Medicine|January 29, 2025
Early-onset sleep alterations found in patients with amyotrophic lateral sclerosis are ameliorated by orexin antagonist in mouse modelsSimon J Guillot, Christina Lang, Marie Simonot, et al.
Pageof 11